New pharmaceutical manufacturing investments are beginning to reshape the U.S. biotech landscape beyond traditional hubs like Boston and Cambridge. According to a report by Alexandra Pecci published on July 6, Lancaster County, Oklahoma City and Las Vegas are attracting major
